{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:48:24Z","timestamp":1782503304381,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastytoday.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.artd.2026.102026","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:09:06Z","timestamp":1780337346000},"page":"102026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of Preoperative Osteoporotic Medications on Total Hip Arthroplasty Outcomes"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4101-7667","authenticated-orcid":false,"given":"Sophia S.","family":"Antonioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cohen-Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.artd.2026.102026_bib1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2106\/JBJS.RVW.16.00002","article-title":"Outpatient total hip arthroplasty, total knee arthroplasty, and unicompartmental knee arthroplasty: a systematic review of the literature","volume":"4","author":"Pollock","year":"2016","journal-title":"JBJS Rev"},{"key":"10.1016\/j.artd.2026.102026_bib2","article-title":"Projections and epidemiology of primary hip and knee arthroplasty in medicare patients to 2040-2060","volume":"8","author":"Shichman","year":"2023","journal-title":"JB JS Open Access"},{"key":"10.1016\/j.artd.2026.102026_bib3","article-title":"Projecting the chronic disease burden among the adult population in the United States using a multi-state population model","volume":"10","author":"Ansah","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.artd.2026.102026_bib4","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.arth.2024.05.081","article-title":"How has the total hip arthroplasty patient population changed? A ten-year analysis of total hip arthroplasty patients from 2013 to 2022: a retrospective, single-center study","volume":"39","author":"Ruff","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib5","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.artd.2026.102026_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.arth.2019.03.044","article-title":"Osteoporosis is common and undertreated prior to total joint arthroplasty","volume":"34","author":"Bernatz","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bone.2006.11.013","article-title":"The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement","volume":"40","author":"M\u00e4kinen","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.artd.2026.102026_bib8","first-page":"370","article-title":"Total hip arthroplasty in patients with osteoporosis","volume":"30","author":"Karachalios","year":"2020","journal-title":"Hip Int J Clin Exp Res Hip Pathol Ther"},{"key":"10.1016\/j.artd.2026.102026_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5371\/hp.2024.36.4.260","article-title":"Total hip arthroplasty in patients with hip osteoporosis: a narrative review","volume":"36","author":"Daher","year":"2024","journal-title":"Hip Pelvis"},{"key":"10.1016\/j.artd.2026.102026_bib10","article-title":"Osteoporosis treatment: current drugs and future developments","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.artd.2026.102026_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.artd.2022.02.003","article-title":"Bisphosphonates in total joint arthroplasty: a review of their use and complications","volume":"14","author":"McDonald","year":"2022","journal-title":"Arthroplasty Today"},{"key":"10.1016\/j.artd.2026.102026_bib12","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1007\/s11999-015-4263-4","article-title":"Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry","volume":"473","author":"Khatod","year":"2015","journal-title":"Clin Orthop"},{"key":"10.1016\/j.artd.2026.102026_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.arth.2015.09.005","article-title":"Lower total knee arthroplasty revision risk associated with bisphosphonate use, Even in patients with normal bone density","volume":"31","author":"Namba","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00167-018-5333-4","article-title":"The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate","volume":"27","author":"Ro","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.artd.2026.102026_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.artd.2026.102026_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.arth.2024.08.043","article-title":"Does preoperative bisphosphonate use impact the risk of periprosthetic fracture following total hip arthroplasty?","volume":"40","author":"Torres","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.arth.2023.08.029","article-title":"Bisphosphonate use may be associated with an increased risk of periprosthetic hip fracture","volume":"39","author":"Serino","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.arth.2023.05.027","article-title":"The effect of preoperative bisphosphonate use on total hip arthroplasty outcomes","volume":"38","author":"Jeong","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/jcm10051140","article-title":"Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making","volume":"10","author":"Hayes","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.artd.2026.102026_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X13477714","article-title":"Bisphosphonate drug holiday: who, when and how long","volume":"5","author":"Diab","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.artd.2026.102026_bib21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.arth.2024.10.003","article-title":"Preoperative osteoporosis is associated with increased health care utilization and compromised pain and function improvement after primary total hip arthroplasty: a prospective cohort analysis","volume":"40","author":"Emara","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbiomech.2018.04.041","article-title":"A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: a randomized placebo-controlled trial of women undergoing total hip arthroplasty","volume":"75","author":"Aro","year":"2018","journal-title":"J Biomech"},{"key":"10.1016\/j.artd.2026.102026_bib23","series-title":"2024 annual report","year":"2024"},{"key":"10.1016\/j.artd.2026.102026_bib24","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1016\/j.arth.2024.06.038","article-title":"Periprosthetic fractures: a rising tide of hip arthroplasty failure noted in the American joint replacement registry and the preventative role of cemented stems","volume":"39","author":"Sassoon","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib25","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.arth.2025.03.080","article-title":"Primary total hip arthroplasty performed in 2022 to 2023 by candidates for the American board of orthopaedic surgery board certification and recertification: fixation and patient age","volume":"40","author":"Garvin","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib26","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/j.arth.2017.05.021","article-title":"What is the difference between modular and nonmodular tapered fluted titanium stems in revision total hip arthroplasty","volume":"32","author":"Huang","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.artd.2026.102026_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jos.2024.01.011","article-title":"Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: a systematic review and network meta-analysis","volume":"30","author":"Hatano","year":"2025","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.artd.2026.102026_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/os.12513","article-title":"Efficiency of zoledronic acid in inhibiting accelerated periprosthetic bone loss after cementless total hip arthroplasty in osteoporotic patients: a prospective, cohort study","volume":"11","author":"Fu","year":"2019","journal-title":"Orthop Surg"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344126000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344126000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:23:19Z","timestamp":1782501799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344126000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S2352344126000750"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2026.102026","relation":{},"ISSN":["2352-3441"],"issn-type":[{"value":"2352-3441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Preoperative Osteoporotic Medications on Total Hip Arthroplasty Outcomes","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2026.102026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.","name":"copyright","label":"Copyright"}],"article-number":"102026"}}